Real-time enrollment status for this malaria, falciparum clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:36 PM UTC
| NCT Number | NCT07670377 |
| Recruiting Status | Recruiting |
| Condition | Malaria, Falciparum |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | July 21, 2026 (Jul 21, 2026) |
As of August 27, 2026: Clinical trial NCT07670377 is currently recruiting participants. This phase1 study for malaria, falciparum is actively seeking new participants at 1 location across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07670377 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07670377 was last updated Jul 21, 2026 (July 21, 2026). HelloStudys verifies this status automatically.